Cellular response to interferon in patients with chronic hepatitis C infection: monitoring the response to improve treatment outcomes.
Phase of Trial: Phase II
Latest Information Update: 15 Jun 2016
At a glance
- Drugs Peginterferon alfa-2a (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 26 Apr 2011 Actual end date (31 Jan 2011) added as reported by UKCRN.
- 26 Apr 2011 Status changed from recruiting to completed as reported by UKCRN.
- 12 Nov 2010 United Kingdom Clinical Research Network reports accrual to date changed from 86% to 97%.